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research protocol, Clinical Radiology (2018)AIM: To evaluate whether a dedicated epilepsy research protocol with expert image re-
evaluation can increase identiﬁcation of patients with lesions and to attempt to ascertain
the potential reasons why lesions were not identiﬁed previously on earlier clinical magnetic
resonance imaging (MRI).
MATERIALS AND METHODS: Forty-three patients (26 female) with focal refractory epilepsy
who had failed at least two trials of anti-epileptic drug treatments were studied. Patients were
recruited prospectively into the study if previous clinical MRI was deemed to be “non-lesional”
by the clinicians involved in the initial assessment. Three-dimensional (3D) T1-weighted
(T1W), T2-weighted (T2W), T2 ﬂuid-attenuated inversion recovery (T2-FLAIR) sequences,
and two-dimensional (2D) coronal T1-/T2W FLAIR were assessed by a neuroradiologist,
including the previous clinical MRI of individual patients.
RESULTS: Twenty-nine or 43 (67%) patients remained MRI-negative after scanning with the
epilepsy-dedicated protocol and image reappraisal by expert consultant neuroradiologists;
however, 14/43 (33%) patients were found to have potentially epileptogenic brain lesions. The
lesion that most frequently escaped the attention of clinicians was hippocampal sclerosis (nine
cases, of which two had an additional focal cortical dysplasia, FCD), followed by single FCDs
(two cases), and others including gliosis, encephalocoele, and amygdala enlargement (one case
each). Eleven of the 14 (79%) previously “non-lesional” patients had electroencephalogram
(EEG) imaging-concordant localisation features, rendering them potential candidates for
resective surgery.
CONCLUSIONS: The primary factors explaining the newly identiﬁed lesions were the choice
of MRI sequences, imaging parameters, data quality, lesion not reported (human factor), and
loss of information through incomplete documentation. It is important for all clinicians to
proceed meticulously in the detailed assessment of epilepsy-dedicated in-vivoMRI and discuss
difﬁcult patient cases in multidisciplinary team meetings.
 2018 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.p, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, Clinical Sciences
Liverpool L9 7LJ, UK. Tel.: þ44-151-529-5467.
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Table 1
Demographic and clinical information.
Variable MRI-positive
patients
MRI-negative
patients
N 14 29
Mean age (SD) in years, range 33.2 (10.9),
18e54
30.8 (11.2),
18e61
Sex (female/male) 10/4 16/13
Mean age at diagnosis (SD) in
years, range
13.9 (11.2),
5e36
16.2 (10.1),
1e47
Mean duration of epilepsy (SD) in
years, range
19.3 (14.1),
1e50
14.6 (9.6),
3e43
History of SGTCS (no/yes) 2/12 9/20
Seizure frequency (SD), per week 4.9 (9.0),
0.04e35
5.8 (10.4)
0.04e46
EEG localisation
(rTL/lTL/rFL/lFL/other)
3/7/0/0/4 5/9/3/5/7
Complications at birth
(unsure/no/yes)
1/12/1 2/24/3
History of brain infection
(no/yes)
12/2 26/3
History of febrile
convulsions (no/yes)
9/5 28/1
All participants underwent the same imaging protocol. No patient had a head
trauma. Details of individual patients can be found in Table 2 and captions of
Figs 1e10. TL, temporal lobe; FL, frontal lobe; r, right; l, left; EEG, electro-
encephalography; SD, standard deviation; SGTCS, secondary generalised
toniceclonic seizure.
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The detection of a brain abnormality on magnetic reso-
nance imaging (MRI)1e4 in addition to concordant focal
electroencephalogram (EEG) spike discharges5e7 has been
related to good surgical outcomes, while patients with no
remarkable MRI ﬁndings are rendered seizure-free less
often.7e9 Unfortunately, it is not uncommon for patients
with severe seizure activity to present with an unremark-
able MRI; however, it is likely that (subtle) epileptogenic
lesions are not detected on routine clinical MRI and
contribute to ongoing seizure activity. It is important that
(1) the MRI protocol and (2) subsequent qualitative and
quantitative assessment of the images is speciﬁcally
tailored for patients with epilepsy so that potentially small
lesions causing debilitating seizures can be detected and
treated. Several publications to date have discussed the
factors that can increase the accuracy of lesion detection
through MRI in clinical practice.10e13 In one study, outcome
after surgery improved signiﬁcantly with the introduction
of an epilepsy-dedicated MRI protocol, which increased the
sensitivity of epilepsy-related lesion detection (e.g., hippo-
campal sclerosis, HS) rather than applying a standardised
MRI protocol.11 Nevertheless, the authors state that even
with a dedicated protocol, optimisation of acquisition pa-
rameters (e.g., angulation according to the presumed
seizure onset zone) may be necessary for individual pa-
tients.11 Overall, when correlating radiological ﬁndings with
histopathology, neuropathological diagnoses were pre-
dicted correctly in 89% of epilepsy-dedicated MRI reports,
but only by 22% of “non-expert” reports (MRI assessed by
radiologists not attached to epilepsy centres) based on
standard MRI.11 Consequently, an early referral to a
specialist epilepsy centre may increase the lesion detection
rate. Hardware may also play a role; Phal et al.14 and Win-
ston et al.15 reported an up to 30% increase in diagnostic
yield of 3 T images versus 1.5 T. These results indicate that
higher signal-to-noise ratio (SNR) facilitates the detection
of focal epileptogenic lesions.
The aim of the present study was to evaluate whether an
epilepsy-dedicated research protocol with expert image re-
evaluation could increase identiﬁcation of patients with
lesions. This required patients to have no discernible brain
abnormality based on a previous clinical MRI (not part of an
epilepsy-dedicated research protocol). This earlier MRI was
included in an evaluation of lesion conspicuity to qualita-
tively re-evaluate factors likely to have contributed to the
new presentation of a lesion. Considering the previous re-
ports of increased diagnostic yield using 3 T as opposed to
1.5 T MRI14,15 and the application of epilepsy-dedicated MRI
protocols,11 the objective of this work was to determine
whether the use of a dedicated epilepsy research protocol in
a specialist hospital of neurology and neurosurgery would
beneﬁt lesion conspicuity and identiﬁcation.
Importantly, MRI could be assessed to illustrate if MRI
hardware, image signal decay due to artefacts (e.g. head
motion), radiological expertise or the protocol had an in-
ﬂuence on the individual diagnosis at the time. Failure toPlease cite this article in press as: Kreilkamp BAK, et al., Neuroradiologic
research protocol, Clinical Radiology (2018), https://doi.org/10.1016/j.cradidentify lesions earlier may have multiple reasons and may
be directly linked to lesion conspicuity. The work conducted
here may provide important clinical information on the
number of patients who have epileptogenic lesions but have
unremarkable MRI by virtue of previous imaging protocols
not specialised for the detection of epileptogenic lesions.
Identiﬁcation of an underlying brain abnormality can
potentially afford important implications for treatment
consequences, such as earlier referral for epilepsy surgery
for patients with medically refractory focal epilepsies. Ac-
cording to Wiebe and Jette,16 surgery is effective but un-
derused. In particular, it has been shown to be cost-
effective,17 to save lives,18 and improve quality of life by
reducing seizure frequency.19 Consequently, epilepsy sur-
gery with appropriate presurgical evaluation may afford
many advantages over the continued use of anti-epileptic
drugs (AED).
Materials and methods
The study was approved by the local ethical board for the
application of MRI scanning and collection of previous
clinical data in patients with refractory focal epilepsy. The
epilepsy-dedicated research protocol was conducted be-
tween November 2014 and April 2016. All participants
provided written informed consent. A 3 Tesla General
Electric Discovery MR750 scanner (Waukesha, WI, USA)
with a 32-channel head coil was used for prospective
acquisition of MRI images. Forty-three patients (26 female;
mean age  standard deviation [SD] ¼ 31.611, range
18e61) with focal refractory epilepsy who had failed at least
two trials of AED treatments were studied. Patients wereal ﬁndings in patients with “non-lesional” focal epilepsy revealed by
.2018.08.013
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MRI was deemed to be “non-lesional” by the clinicians
involved in the initial assessment, which included general
radiologists at other trusts and neuroradiologists at the
authors’ centre. Localisation of seizure onset had been
thoroughly evaluated using seizure semiology and scalp
EEG investigations.
The epilepsy-dedicated research protocol included a
three-dimensional (3D) axial T1-weighted (T1W) fast-spin-
gradient (FSPGR) with phased-array uniformity enhance-
ment (PURE) signal inhomogeneity correction (140 sec-
tions, repetition time [TR]¼8.2 ms, inversion time [TI]¼450
ms, echo time [TE]¼3.22 ms, ﬂip angle¼12, with 1 mm
isotropic voxel size, acquisition time: 3:48 minutes) for all
participants. Axial 3D T2-weighted (T2W) turbo spin echoFigure 1 Common Lesions in Focal Epilepsy: Right HS shown on T2-FLA
superior parietal lobule (bottom) (B). (A) HS: The T2-FLAIR image shows
demonstrates hypointensity of the hippocampal formationwith a marked
is only marginally visible in both images. T1-FLAIR and T2-FLAIR show b
occurring with HS. (B) FCD: The related signal appears dark on T1-w and
report (our center) stated that the two dysplastic sites may be interco
dysplasia. Images acquired at our center.
Please cite this article in press as: Kreilkamp BAK, et al., Neuroradiologic
research protocol, Clinical Radiology (2018), https://doi.org/10.1016/j.crad(TSE) with variable ﬂip angle (CUBE) images (with PURE
correction, 312 slices, TR¼2,500 ms, TI ¼ N/A, TE¼71.2 ms,
ﬂip angle¼90, with 0.5 mm isotropic voxel size), and 3D
sagittal CUBE T2 ﬂuid-attenuated inversion recovery (T2-
FLAIR) with PURE (312 sections, TR¼6,000 ms, TI¼50 ms,
TE¼127.1 ms, ﬂip angle¼90 with 0.5 mm isotropic voxel
size) were also acquired. Additionally, T1-FLAIR coronal (52
sections, TR ¼ N/A, TI ¼ 920 ms, TE ¼ 9.94 ms, ﬂip angle ¼
111, voxel size ¼ 0.40.43mm) and a T2-FLAIR coronal
image (40 sections, TR¼ 12,000ms, TI¼ 2,713ms, TE¼ 98.7
ms, ﬂip angle¼160, voxel size¼ 0.860.864 mm) aligned
with the long axis of the hippocampus were acquired for all
patients. In those patients, who had a lesion identiﬁed on
the most recent dedicated epilepsy research MRI, the pre-
vious clinical MRI was re-assessed by two expertIR/T1-FLAIR (A) and FCD in the left supramarginal gyrus (top) and
hyperintense signal in the hippocampal region, while the T1-FLAIR
volume loss. The loss of internal architecture in the right hippocampus
lurring of the parahippocampal WM, which is a frequent ﬁnding co-
bright on T2-w/T2-FLAIR 3D volume images. The neuroradiologist’s
nnected. L ¼ left. HS ¼ hippocampal sclerosis. FCD ¼ focal cortical
al ﬁndings in patients with “non-lesional” focal epilepsy revealed by
.2018.08.013
Table 2
Patient demographic/clinical information and recent MRI ﬁndings for patients with newly diagnosed epileptogenic lesions.
ID Sex Age
(years)
Infection/febrile
convulsion
Onset
(age, years)
Duration
(years)
EEG Type Frequency
(per week)
Finding
22 F 54 No/no 5 50 Right TL SPS, SGTCS, CPS 2 Right HS & small-vessel disease
24 F 39 Yes/yes 36 2.5 Right TL SGTCS 0.5 Right HS & right cerebello-pontine
angle cystic lesion e epidermoid
25 M 47 No/no 34 13 Bilateral TL A, SGTCS, CPS 2 Bilateral HS
27 F 38 No/yes 7 31 Left TL CPS, SGTCS 0.5 Left HS
38 F 30 No/no 15 15 Left TL SGTCS 1 Left HS
51 F 43 No/yes 6 37 Left TL SGTCS, CPS 2 Left HS & left TL pole FCD & small-vessel
disease/Rasmussen’s/encephalitis
56 F 23 Yes/no 6 17 Right TL A, CPS 2.5 Right HS and right parahippocampal FCD
59 F 27 No/no 6 21 Bilateral FL CPS, SGTCS 7 FCD in left supramarginal gyrus &
left parietal lobule
61 F 36 No/yes 30 6 Left TL SGTCS 0.04 Left temporal encephalocoele
65 M 22 No/no 5 17 Left TL A, CPS, SPS, SGTCS 6 FCD/gliosis in right superior frontal gyrus
66 M 18 No/no 10 8 Left TL CPS, SPS, SGTCS 1 Left HS
69 M 29 No/no 10 19 Right TP CPS, SGTCS 7 Right cortical gliosis (widespread)
81 F 40 No/yes 7 33 Left TL A 2 Left HS
84 F 19 No/no 18 1 Left FT CPS, SGTCS 35 Left amygdala enlargement
Bold patient IDs indicate that the previous MRI was available for assessment (n¼8).
F, female; M, male; HS, hippocampal sclerosis; SPS, simple partial seizures; SGTCS, secondary generalised toniceclonic seizures; A, absence seizures; CPS,
complex partial seizures; TL, temporal lobe; FL, frontal lobe; TP, temporoparietal; FT, frontotemporal; FCD, focal cortical dysplasia.
B.A.K. Kreilkamp et al. / Clinical Radiology xxx (2018) 1e114neuroradiologists. This included data from patients ac-
quired on 1.5 and 3 T systems, with and without dedicated
clinical epilepsy protocols. The previous clinical MRI images
were re-evaluated in order to determine the factors inﬂu-
encing the accuracy of visual lesion detection. Two neuro-
radiologists with long-term experience in evaluating MRI of
patients with epilepsy performed reassessment of the im-
ages independently from one another. Demographic and
clinical information for all patients are summarised in
Table 1.Results
Twenty-nine of the 43 (67%) patients remained MRI
negative after assessment of the epilepsy-dedicated MRI byFigure 2 Patient 22: right HS and Small-Vessel Disease. In 2014 this patie
T1-FLAIR coronal sequence shows a comparable quality relative to the mo
detected by the neuroradiologist. HS and WM lesions related to small ves
image relative to the 2014 T2-FLAIR image, the latter of which suffers fro
Please cite this article in press as: Kreilkamp BAK, et al., Neuroradiologic
research protocol, Clinical Radiology (2018), https://doi.org/10.1016/j.cradthe consultant neuroradiologists; however, 14/43 (33%)
patients were found to have potentially epileptogenic brain
lesions, such as HS and focal cortical dysplasia (FCD), shown
in Fig 1. Diagnostic information for these patients is pre-
sented in Table 2.
All available images are presented in the results sec-
tions along with clinically relevant information for each
patient. Eleven of the 14 (79%) previously “non-lesional”
patients had EEG imaging-concordant localisation fea-
tures (except for patients 59, 65, and 84) rendering them
potential candidates for resective surgery. Surgical candi-
dacy had been assessed during the multidisciplinary team
meetings that consider results from MRI, neurophysio-
logical, and neuropsychological evaluation. For eight of
the 14 patients (57%) previous MRI examinations (from
the authors’ centre and another) were available fornt received a dedicated epilepsy protocol at our center. Although the
st recent 2015 T1-FLAIR, Small Vessel Disease and right HS were not
sel disease are increasingly conspicuous on the most recent T2-FLAIR
m lower SNR. R ¼ right.
al ﬁndings in patients with “non-lesional” focal epilepsy revealed by
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Figure 3 Patient 24: right HS. While early images do not show clear evidence of HS, the expert neuroradiologist termed this as “small right
hippocampus” without explicitly diagnosing HS. This was inappropriately documented and this information did not reach the consultant
neurologist. In the later image right HS was re-diagnosed. R ¼ right.
B.A.K. Kreilkamp et al. / Clinical Radiology xxx (2018) 1e11 5retrospective evaluation. The remaining images could not
be retrieved as they had been acquired at other hospitals.
This section initially presents the eight cases with a new
identiﬁable lesion for whom previous MRI studies were
available (Figs 2e9). Subsequently, the remaining six cases
for whom previous MRI was not obtainable are presented
(Fig 10). The reasons for lesions not being reported in this
dataset were multifactorial and were due to the following
factors (Table 3): (1) general technical issues affecting
image quality and lesion conspicuity: (i) low SNR (Fig 2)
and movement artefacts (Fig 3) have contributed to loss of
lesion conspicuity on the T2-FLAIR images. Consequently,
the lesion was not identiﬁed as HS (Figs 2 and 3); (ii) the
previous MRI, which was not part of a dedicated epilepsy
research protocol, had technical issues, and therefore, didFigure 4 Patient 25: bilateral HS. The images from 2009 show bilateral H
T1-FLAIR; this was referred to as “bilateral small hippocampi” by the ex
information did not reach the consultant neurologist. In 2015 the patient
Please cite this article in press as: Kreilkamp BAK, et al., Neuroradiologic
research protocol, Clinical Radiology (2018), https://doi.org/10.1016/j.cradnot clearly show the lesion (poor angulation along the
long axis of the hippocampus, Fig 7; large section thick-
ness, Figs 8 and 9); (2) human factors leading to lesions not
being identiﬁed: (i) the clinical team previously evaluating
the patient cases did not document lesion (Figs 5 and 6);
(ii) the standard MRI was reviewed and reported as “non-
lesional” by a general radiologist, although the lesion was
visible (Fig 7); (iii) loss of information during communi-
cation: the neuroradiologist referred to the abnormality
without stating “hippocampal sclerosis”, and subse-
quently, the information was documented inappropriately
(Figs 3 and 4). Rather, the hippocampi for these patients
were referred to as “small”, e.g., “small appearance of the
left hippocampus” (patient 24) and “bilateral small
hippocampi” (patient 25).S as demonstrated by hyperintensity on T2-FLAIR and volume loss on
pert neuroradiologist. This was inappropriately documented and the
was diagnosed with bilateral HS. R ¼ right.
al ﬁndings in patients with “non-lesional” focal epilepsy revealed by
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Figure 5 Patient 38: left HS. Despite signal hyperintensity on T2-FLAIR and volume loss on T1-FLAIR, HS was only diagnosed in 2015. Lesion
conspicuity was similar for both MRI sessions. R ¼ right.
B.A.K. Kreilkamp et al. / Clinical Radiology xxx (2018) 1e116In-vivo MRI is the most reliable and frequent imaging
method used to provide information on macroscopic brain
structure, and in the presence of varying data quality, it is
often impossible for neuroradiologists to evaluate the def-
inite presence of lesions. The lesion that most frequently
escaped the attention of clinicians was HS (nine cases, of
which two had an additional FCD), followed by FCDs (two
cases), and others including gliosis, encephalocoele, and
amygdala enlargement (one case each).
The previous images for patients 27, 51, 59, 69, 81, and 84
could not be retrieved. All lesions reported for these pa-
tients were conspicuous on the most recent images ac-
quired using the dedicated epilepsy research protocol
(Fig 10). So far, ﬁve patients (patient 22 with right HS; 38
with left HS; 56 with right HS; 66 with left HS; 81 with left
HS) have received ipsilateral temporal lobectomies. All
resected specimens had histological conﬁrmation of HS.20
These patients have been followed up at various time
points after surgery (2 years, 2 years, 1 year, 3 months, and
1 week, respectively) and classiﬁed according to the
International League Against Epilepsy (ILAE) outcomeFigure 6 Patient 66: left HS. This patient received comparable quality of ep
was only diagnosed on the later images, which show hyperintensity on T
MRI sessions. R ¼ right.
Please cite this article in press as: Kreilkamp BAK, et al., Neuroradiologic
research protocol, Clinical Radiology (2018), https://doi.org/10.1016/j.cradclassiﬁcations.21 Patients 22, 56, 66, and 81 are currently
seizure free (ILAE I). Patient 38 no longer experiences sec-
ondary generalised toniceclonic seizures (SGTCS), and now
experiences one short (<10 seconds) focal seizure per week,
which represents a substantial improvement (ILAE III).
Three other patients (51, 59, and 61) are still being consid-
ered for surgery.Discussion
The objective of the present study was to employ an
epilepsy-dedicatedMRI protocol in a cohort of patients with
refractory focal epilepsy whowere deemed previously to be
non-lesional on clinical MRI. Thirty-three percent of all
patients recruited had a newly identiﬁed brain lesion. The
primary factors explaining the newly identiﬁed lesions
were the choice of MRI sequences, imaging parameters (in
particular, no previous use of a dedicated epilepsy research
protocol, including the lack of angulation orthogonal to the
long axis of the hippocampus and large section thickness),ilepsy-dedicated imaging in March and November 2015. However, HS
1-FLAIR and HA on T1-FLAIR. Lesion conspicuity was similar for both
al ﬁndings in patients with “non-lesional” focal epilepsy revealed by
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Figure 7 Patient 56: right HS with parahippocampal WM blurring. In 2012 this patient received imaging at a general hospital (left: T2-w; right:
T1-w Inversion Recovery) with an angulation not orthogonal to the long axis of the hippocampus. HS and parahippocampal WM blurring are
more conspicuous on the epilepsy research image of 2015 (left: T2-FLAIR; right: T1-FLAIR), particularly relative to the contralateral hemisphere.
R ¼ right.
Figure 8 Patient 61: left temporal encephalocele. Left temporal encephalocele was diagnosed based on a 3D volume T2-w acquisition, which is
not routinely acquired in the evaluation of patients with epilepsy at our center but was part of the study’s dedicated epilepsy research protocol.
Note how the lesion is more conspicuous on the T2-w image (below) compared to the T1-w (top). Diagnosis was later conﬁrmed with computed
tomography imaging. Older MRIs (all 2D) with large slice thickness (w5 mm) from 2009 failed to reveal this abnormality. L ¼ left; R ¼ right.
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Figure 9 Patient 65: FCD / gliosis in right superior frontal gyrus. Diagnosis was made based on the 3D T2-FLAIR image of 2015 (green image
borders). The abnormality was not reported on the previous 2D axial T2-w image (red image borders) where only one slice showed the small
abnormality. R ¼ right.
B.A.K. Kreilkamp et al. / Clinical Radiology xxx (2018) 1e118data quality (motion artefacts and low SNR), human factors
(lesion not reported), and loss of information through
incomplete documentation (wording: “small hippocampus”
instead of “hippocampal sclerosis”).
The results presented here indicate that one important
factor why lesions had previously escaped the attention
of the reporting neuroradiologist may be the choice of
sequence with lesions being more conspicuous on dedi-
cated epilepsy protocols.10e13 According to Duncan et al.
2016,12 Duncan 199722 and ILAE 1997,10 3D whole-brain
T1W and T2W and 2D FLAIR imaging should be included
in an effective epilepsy-dedicated protocol. Additionally,
apart from the speciﬁc choice of the sequence itself, lesion
conspicuity may be inﬂuenced by data quality, section
thickness, angulation, and resolution. Expert neuroradiol-
ogist reassessment using epilepsy-dedicatedMRI can detect
HS with sensitivity and speciﬁcity of >90%.11,23 Two images
not routinely acquired in the evaluation of patients with
epilepsy at the authors’ centre proved useful for the
detection of FCDs/gliosis (3D T2-FLAIR) and encephalo-
coeles (3D T2W). Tschampa et al.24 indicated previously that
2D/3D T2-FLAIR sequences are equally useful for detecting
FCDs visually, while Friedman13 stated that the whole-brainPlease cite this article in press as: Kreilkamp BAK, et al., Neuroradiologic
research protocol, Clinical Radiology (2018), https://doi.org/10.1016/j.cradcoronal 3D T2W sequence can be helpful in detecting
encephalocoele and may be superior over T1W se-
quences.25 Encephalocoeles may be an under-appreciated
aetiology of temporal lobe epilepsy.26 Additionally, an
isotropic voxel size may increase the diagnostic yield as it
can cover multiple locations within the brain and may
identify small lesions, such as encephalocoeles or gliosis. It
has been previously reported that image artefacts, such as
subject motion, can affect lesion conspicuity.14 As a rule,
when patients moved excessively during the recently
applied epilepsy research dedicated protocol, MRI was
reacquired in order to avoid motion artefacts. High lesion
conspicuity on good-quality MRI is the core characteristic
for the neuroradiologist to be able to conﬁdently report an
abnormality. For patients who remain “non-lesional”, it
may be apt to also acquire 3D T2-FLAIR and 3D T2W data as
these sequences can increase the lesion pick-up-rate, are
easily implemented, and can be performed at low cost
concerning acquisition times. As a direct result of this
translational study using research-dedicated MRI, clinicians
at The Walton Centre NHS Foundation Trust have now
started to request 3D T2-FLAIR images for patients with
refractory focal epilepsy and previous inconclusive MRI.al ﬁndings in patients with “non-lesional” focal epilepsy revealed by
.2018.08.013
Figure 10 Formerly ‘non-lesional’ cases showing lesions using the epilepsy dedicated research protocol. Numbers refer to patient IDs. Please
refer to Table 2 for details on each lesion identiﬁed. R ¼ right.
B.A.K. Kreilkamp et al. / Clinical Radiology xxx (2018) 1e11 9Regarding human factors, the lesion most frequently left
unreported was HS (nine cases), which was also reported in
a previous study.11 These authors reported that HS was
overlooked in 86% of cases when the MRI was read by
general radiologists relative to expert neuroradiologists. In
this sample, FCDs accounted for the second most frequent
lesions left unreported (four cases). These results corre-
spond to those found by Stevens27 where routine MRI failed
to showHS in all cases and FCDs in 20% of all cases. Multiple
sites of gliosis and a single unilateral amygdala enlargement
were identiﬁed in two different patients on their most
recent epilepsy-dedicated research MRI conducted in the
context of this study. Unfortunately, the previous MRI was
not available in these cases. Zubkov et al.28 described aPlease cite this article in press as: Kreilkamp BAK, et al., Neuroradiologic
research protocol, Clinical Radiology (2018), https://doi.org/10.1016/j.cradpatient with a hypothalamic hamartoma (HH) who did not
beneﬁt from right temporal lobectomy as his HH (possibly
also involved in the epileptogenic network)was overlooked.
He then had the HH removed and consequently suffered
severe memory problems (amnesia). This case illustrates
the need to assess for dual (or even multiple) pathology in
treatment of pharmacoresistant epilepsy prior to surgery.
The review presented here has shown several patients with
multiple lesion sites; therefore, it is important that neuro-
radiologists are aware of the satisfaction-of-search effect29
and continue radiological assessment even when epilepsy-
related lesions have already been identiﬁed. Importantly,
based on the present results, a differential checklist has
been devised for radiologists when assessing the presenceal ﬁndings in patients with “non-lesional” focal epilepsy revealed by
.2018.08.013
Table 3
Lesions found in the most recent MRI and retrospective comparison to previous MRI and reports.
ID 22 24 25 38 66 56 61 65
Lesion Right HS &
Small-
vessel-disease
Right HS & right
cerebello-pontine
angle cystic lesion -
epidermoid
Bilateral HS Left HS Left HS Right HS and right
parahippocampal
FCD
Left temporal
encephalocoele
FCD/gliosis in
right superior
frontal gyrus
MRI Epilepsy
protocol
at OC
Epilepsy
protocol at OC
Epilepsy
protocol
at OC
Epilepsy
protocol
at OC
Epilepsy
protocol
at OC
Standard protocol
at other hospital
Epilepsy
protocol
at OC
Epilepsy
protocol
at OC
Reason Low SNR Motion artefacts
and human factor:
documentation
Human factor:
documentation
Human factor:
not reported
Human factor:
not reported
Angulation not
orthogonal to the
long axis of the
hippocampus
2D MRI only
(large slice
thickness,
w5 mm)
2D MRI only
(large slice
thickness,
w5 mm)
Figure 2 3 4 5 6 7 8 9
Epilepsy protocol: The initial epilepsy protocol at our centre (OC) involved only higher resolution in-plane 2D sequences for patients with presumed seizures
(no 3D images).
Epilepsy-dedicated research protocol: 2D coronal FLAIR MRI with high in-plane resolution (w0.5 mm), 3D T1W/T2W/T2FLAIR imaging. 3D sequences were
reserved for pre-surgical work-up, for instance (1) MRI-negative image with indication of a strong EEG localisation and (2) presumed lesions in patients with
MRI-positive ﬁndings for further evaluation and characterisation. Technical reasons for previous MRI-negative report are shown in italics.
OC, The Walton Centre NHS Foundation Trust; HS, hippocampal sclerosis.
B.A.K. Kreilkamp et al. / Clinical Radiology xxx (2018) 1e1110of a lesion: (1) medial temporal lobe on coronal T1-FLAIR/
T2-FLAIR (especially for patients with complex partial sei-
zures) to investigate for HS; (2) cortical thickening and
blurring of greyewhite matter margin on T1W image for
FCD; (3) ﬂoor of the middle cranial fossa on T2W images for
encephalocoeles; and (4) subtle cortical and subcortical
white matter hyperintensity on T2-FLAIR image for gliosis.
Another important point relates to the communication
between neuroradiologists and clinicians. A recent study on
patients with frontotemporal dementia has found that
diagnostic information may be reported inappropriately
(with a limited factual description and incomplete
misleading interpretation of MRI) unless MRI images are
jointly reviewed and discussed by neurologists and neuro-
radiologists.30 In the present study, the apparent hesitation
in ofﬁcially diagnosing hippocampal volume loss on MRI as
HS has resulted in two patients being misclassiﬁed as non-
lesional. Therefore, clinicians may beneﬁt from an equidis-
tant rating scale where it is possible for the neuroradiologist
to indicate how conﬁdent they are in reporting an abnor-
mality and to state reasons for why their conﬁdence is very
high/high/medium/low or very low (e.g., due to slice
angulation/motion artefacts). A similar rating scale has been
used by some centres to record the degree of atrophy in
patients,30e32 the likelihood of presence of FCD33 and ar-
tefacts.14 A conﬁdence rating scale may facilitate reac-
quisition with appropriate and individualised sequence
parameters if necessary, but certainly this should be subject
to further research.
Even though the true-positive rate of 33% within this
investigation of a realistic clinical setting is large and
potentially clinically signiﬁcant for individual patients, one
limitation remains the fact that results are based on a small
sample size. Another limitation of this dataset is that it does
not allow the direct comparison of individual sequence
acquisition parameters or of MRI hardware. The type of MRI
sequences and the data quality varied for all initial clinical
MRI studies, which were not part of the more recently
applied epilepsy-dedicated protocol and acquired atPlease cite this article in press as: Kreilkamp BAK, et al., Neuroradiologic
research protocol, Clinical Radiology (2018), https://doi.org/10.1016/j.craddifferent time points. As in the example of an initial nega-
tive report based on MRI with poor quality and lesion
conspicuity, the lesion may not have been appreciated due
to artefacts, human factors or both (i.e., retrospectively the
lesion is discernible on the initial MRI evenwhen taking the
artefacts into account). This also reﬂected the opinion of the
consultant neurologist and neuroradiologists who retro-
spectively re-evaluated the initial MRI images: in almost all
cases the reasons for leaving an abnormality unreported
remain multifactorial. Consequently, this made it difﬁcult to
attribute a single reason to leaving a lesion unreported. A
prospective study where MRI is evaluated by an expert
neuroradiologist in a blinded fashion (e.g., one with motion
artefacts, one without in the same patient, etc.) may resolve
some of these open questions. Nevertheless, this retro-
spective study of previous MRI in a realistic clinical setting
was capable of shedding light on the factors that may in-
ﬂuence everyday clinical practice. An acknowledgement of
these being multifactorial may facilitate a deeper under-
standing and re-evaluation of current MRI protocols,
neuroradiological assessment, and communication be-
tween clinicians.
In conclusion, it is important for all clinicians to un-
dertake detailed assessment of MRI images and discuss
difﬁcult patient cases in MDT meetings. Ultimately,
consideration of all the interdependent factors mentioned
in this review have important implications for (i) treatment
options for the individual patient, especially regarding
epilepsy surgery performed on newly identiﬁed epilepto-
genic lesions; and (ii) study populations that may have
been confounded by undetected lesions in patient samples
if sequences were not dedicated to depicting epilepsy le-
sions and MRI was not reassessed by an expert neurora-
diologist. These factors may inﬂuence everyday clinical
practice and research into lesional/”non-lesional” epilepsy.
As some lesions may be too subtle to appreciate on MRI,
even via expert neuroradiological assessment, it is impor-
tant to develop automated lesion analysis tools, which
allow reliable whole-brain quantitative comparison of aal ﬁndings in patients with “non-lesional” focal epilepsy revealed by
.2018.08.013
B.A.K. Kreilkamp et al. / Clinical Radiology xxx (2018) 1e11 11single patient’s MRI with those acquired from healthy
controls.
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